Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Follow the firms, the rounds and the people behind them.
Firms, funds, rounds and the people behind them, read from filings and announcements. Free to read, with the source and the date on every row.
What are you trying to do?
Who is funding what, who co-invests with whom, and which firms are active right now.
- Firms and funds
- Co-investor pairs
- Rounds on the record
The firms that actually write cheques at your stage, and the partners who lead them.
- Partners who lead rounds
- The firm behind each one
- What they have already funded
Fund filings, limited partners on the record and what peers of your size have closed.
- Funds and filings
- Limited partners
- Peer closings
Or keep reading. Everything below is public, and picking a door only changes what leads.
Search by what an investor has done, not what its website says
Every organization here entered through a public record: a Form ADV filing that claims the venture capital fund adviser exemption or reports venture funds, a Form D venture vehicle, a portfolio page, or a cited announcement. The class chip says what kind of organization it is and how sure we are; the profile says why. Candidates are shown as candidates and are not counted as coverage.
venture manager, reported GAV $1,006M across 22 vehicles
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
High-conviction seed partners to founders transforming critical industries. $100M invested in 72 companies building AI, robotics, and enterprise infrastructure.
Building deep tech companies powered by material science.
venture manager, reported GAV $610M across 12 vehicles
venture manager, reported GAV $1,001M across 69 vehicles
registered adviser; venture funds are 0% of 42 private funds
both early and growth/opportunity families, reported GAV $95M
U••••••••• VC is a Boston-based venture capital firm backing bold early-stage B2B software founders at Pre-Seed and Seed.
W•••••• Capital is an industry leading private holding firm that partners and invests in growing private businesses and their management teams.
S•••••• T••••••••• is a venture capital platform funding the next generation of companies solving built environment challenges.
B•••••• Global Advisors provides investment solutions and family office services for venture capital and private equity executives.
corporate parent: Blackstone Inc.
Series A investor in fast-scaling B2B AI, software, fintech, and hardware startups.
no venture fund on Form ADV; public LPs book its vehicles as Growth Equity
registered adviser; venture funds are 24% of 15 private funds
A•••••••• Capital™ is a global growth equity investor with $1 billion AUM that focuses on growth-stage companies in AI, data infra, cybersecurity, etc. Founded in 2018, the firm employs a distinctive, highly research-driven approach. Headquartered in Boston, with investment teams in NYC and San Francisco, A•••••••• Capital™ partners with category-defining entrepreneurs to shape the future.
corporate parent: the Ag
G•••••••• G••••• Equity is a Boston-based firm with years of operating and functional experience partnering with growth-stage companies using technology to transform industries.
Founded in 2004, H••••••• Equity Partners is the preferred capital partner to founders and owner-operators of lower, middle-market businesses in North America.
True partners for each step of your search fund journey.
W••• V•••••••, Early-stage teammates for consumer, health, and media startups.
G20 Ventures is the capital partner that helps new businesses grow with smart money, great storytelling, and the right connections.
Rhapsody Venture Partners invests in early stage, hard-tech innovations -- things like new materials, engineering innovations, chemistries, food tech -- helping bring them from the lab to market.
venture manager, reported GAV $285M across 42 vehicles
A••••• Ventures invests in breakthroughs that could avert catastrophic climate change. We partner with visionary founders for solutions.
Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.
Providing Growth Equity Financing to Healthcare Companies for Over 30 years. Our B•••••-based venture capital investing philosophy is guided by our Core Company Investment Strategy, which accelerates the growth of a company through strategic consolidation within an industry. Focused on the “buy-and-build” strategy to support startups and entrepreneurs.
Impact the world with ESG impact investing and W••• E••••• P•••••••, investing in generational green, sustainable and clean energy companies.
Early-stage capital backing the next generation of frontier technology, critical infrastructure, and applied AI.
registered adviser; venture funds are 0% of 18 private funds
Founded in 2019, we’re privileged to partner with uniquely bold, disruptive early-stage companies that are advancing healthcare, generating strong returns, and saving lives. And we are having a bit of fun while doing it.
The official site of SoftBank Group Corp. (Chairman & CEO: Masayoshi Son). Discover our philosophy, investor relations, company information, business segments & group companies, and sustainability (ESG) initiatives.
One firm, 2 filing advisers on c•••••••••.com · C•••••••
venture manager, reported GAV $287M across 1 vehicles
venture manager, reported GAV $140M across 6 vehicles
B••••••• Ventures is a venture capital firm based in Boston, MA. We partner with Built Environment entrepreneurs and early-stage startups.
venture manager, reported GAV $254M across 2 vehicles
One firm, 2 filing advisers on n•••••••••.com · N•••• B•••••
venture manager, reported GAV $618M across 6 vehicles
Defining the future of business solutions.
N•••••• Partners is a multi-stage life sciences and healthcare venture capital firm based in Boston, MA.
T••••••• Ventures partners with entrepreneurs to solve meaningful problems across the Enterprise landscape through technology-enabled solutions that have lasting value in the networks, data, and platforms they create.
B••••••• is a collective of creative technologists advancing the art of building companies at the frontiers of technology and design.
no sworn venture fact yet (name or round mention only)
C••••.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to raise an awesome next round of financing.
One firm, 3 filing advisers on v•••••••••.com · V••• V•••••••
venture manager, reported GAV $640M across 4 vehicles
Standard of C••• Embracing Evidence. Increasing Success. Saving Lives. How We Go All-In With Entrepreneurs, We Bring C•••s to Life Learn More Our People Moving Medicine Forward Dr. Michael Aberman XenImmune Leveraging the robust immune response to target tumors like never before. Read Michael’s Story Dr. Milenko Cicmil Tasca Therapeutics Unlocking post-translational modification to expand […]
venture manager, reported GAV $100M across 8 vehicles
B•••: Investing at the intersection of the digital and physical worlds
R••• P••• A•••••••• L•• is a specialized investment firm that applies the theory of disruptive innovation.
venture manager, reported GAV $63M across 6 vehicles
The rest of the firm names are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
The record above stays free. What you pay for is the depth behind it.
Free to read. $199 a month to work in.
The full comparisonNo account. What a visitor and a search engine both see.
- Every entity by name, with its type and its record
- The dated public tape: what changed and when
- The source and the date on every published row
- The methodology, in full
Enough to be useful on its own, and it is how we learn what you came for.
- Follow entities and get a weekly digest of what moved
- Save searches and keep one universe
- A small monthly reveal allowance, to see what a contact looks like
- A small export, with its source column
or 10 months paid yearly. The working tier: the depth and the reach behind every lock on this vertical.
- Reveal the published contact line, with its source
- The whole change history on any record, back to first seen
- Every filter, across the whole record rather than the first page
- CSV export with the source column intact
- 250 follows, 25 saved screens, 5 universes
For the people who work this market every day rather than look things up in it.
- Alerts the day something moves, on an entity, a screen or a universe
- Continuous monitoring with a daily digest
- Exports at the size you actually load into a CRM
- A reveal allowance for a working desk, not a sample
- 2,000 follows, 100 saved screens, 25 universes
All nine verticals, and the joins between them. The one thing here that no list you can buy anywhere else contains.
- Every vertical, at Pro depth
- The same entity across all nine graphs, joined on identity
- Cross-graph search, universes and alerts
- One invoice instead of a collection of subscriptions
The family offices behind the LP line in these funds.
$249 / month
Where these companies go after venture.
$249 / month
The institutions that commit to funds at this stage.
$299 / month
Each is its own subscription. Three or more and the whole Factory costs less, at $599 a month for all nine.
Every row on this page carries its source and its date. The methodology says what is measured, what is inferred, and what DFX does not claim. The Data Factory is this and eight other graphs, joined.